Examkin

Question

Difficulty: MediumGynecologic Oncology

An outpatient evaluation is requested for a 41-year-old woman experiencing abnormal uterine bleeding. Over the last 10 months, her menstrual cycles have become highly irregular, occurring at intervals ranging from 20 to 60 days. The periods are characterized by a heavy flow that frequently requires changing a superabsorbent pad every hour during the first two days of menstruation. Her past medical history includes essential hypertension and type 2 diabetes mellitus. Her body mass index is 39 kg/m2. She has never been pregnant. Vital signs are normal. Speculum examination shows a normal-appearing cervix with a moderate amount of dark blood in the vaginal vault. Bimanual examination reveals a mobile, normal-sized uterus and no adnexal masses. Urine human chorionic gonadotropin testing is negative. Transvaginal ultrasonography shows a homogeneously thickened endometrium measuring 14 mm without focal lesions. Which of the following is the most appropriate next step in the management of this patient?

  1. Endometrial biopsyAnswer
  2. B
    Hysteroscopy with dilation and curettage
  3. C
    Insertion of a levonorgestrel-releasing intrauterine device
  4. D
    Prescription of combined oral contraceptive pills
  5. E
    Repeat transvaginal ultrasound in 3 months

Answer

Endometrial biopsy is the most appropriate next step.
An endometrial biopsy is the definitive next step for this patient. The primary concern in patients with heavy, irregular menstrual bleeding and risk factors for unopposed estrogen is endometrial hyperplasia or endometrial adenocarcinoma. Unopposed estrogen occurs due to peripheral aromatization of androgens to estrone in adipose tissue, a process heavily exacerbated by obesity. While routine endometrial sampling for abnormal uterine bleeding is generally recommended for women aged 45 and older, it is explicitly indicated in women under 45 who have additional high-risk factors such as obesity, chronic anovulation, diabetes mellitus, or nulliparity. Since this patient meets multiple high-risk criteria and has a notably thickened endometrium (14 mm) on ultrasound, an office endometrial biopsy is required to rule out malignancy before any symptomatic treatment can be safely prescribed.

Step-by-Step Solution

1
Identify the primary clinical problem and patient demographic.
The patient is a 41-year-old (premenopausal) woman presenting with abnormal uterine bleeding (AUB).
Establishing the patient's age and menopausal status determines the diagnostic algorithm for uterine bleeding.
2
Assess the patient for specific risk factors associated with endometrial hyperplasia and cancer.
The patient has significant risk factors for unopposed estrogen exposure: obesity (BMI 39), type 2 diabetes, and nulliparity.
Endometrial cancer risk relies heavily on the presence of excess unopposed estrogen, which drives endometrial proliferation.
3
Determine the appropriate guideline-based indication for endometrial tissue sampling in AUB.
Guidelines dictate that women < 45 years old with AUB require an endometrial biopsy if they have a history of unopposed estrogen exposure, failed medical management, or conditions like Lynch syndrome.
Although the standard age threshold for universal biopsy in AUB is 45 years, the presence of these high-risk factors in younger women mandates immediate tissue sampling to rule out malignancy before initiating medical therapy.

Key Concept

Premenopausal women younger than 45 years with abnormal uterine bleeding require an endometrial biopsy if they possess risk factors for unopposed estrogen exposure (e.g., obesity, polycystic ovary syndrome, nulliparity, diabetes mellitus).
Estimated Time:1m 15s
Rate this question

Topics

Gynecologic Oncology

More questions from this topic